Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...
The U.S. Food and Drug Administration (FDA) has approved a new drug for the treatment of moderate-to-severe pain that is a non-opioid and carries less risks of addiction than opioids. Journavx works ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.